Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

Tjalf Ziemssen; Ovidiu A Bajenaru; Adriana Carrá; Nina de Klippel; João Correia de Sá; Astrid Edland; Jette L Frederiksen; Olivier Heinzlef; Klimentini E Karageorgiou; Rafael H Lander Delgado; Anne-Marie Landtblom; Miguel A Macías Islas; Niall Tubridy; Yossi Gilgun-Sherki

doi:10.1007/s00415-014-7565-7

Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

Tjalf Ziemssen, Ovidiu A Bajenaru, Adriana Carrá, Nina de Klippel, João Correia de Sá, Astrid Edland, Jette L Frederiksen, Olivier Heinzlef, Klimentini E Karageorgiou, Rafael H Lander Delgado, Anne-Marie Landtblom, Miguel A Macías Islas, Niall Tubridy, Yossi Gilgun-Sherki

Afdeling for Hjerne- og Nervesygdomme

Originalsprog	Engelsk
Publikationsdato	jan. 2015
Vol/bind	262
DOI	https://doi.org/10.1007/s00415-014-7565-7
Status	Udgivet - jan. 2015

Navn	Journal of Neurology
ISSN	0340-5354

Adgang til dokumentet

10.1007/s00415-014-7565-7

Citationsformater

Ziemssen, T., Bajenaru, O. A., Carrá, A., de Klippel, N., Correia de Sá, J., Edland, A., Frederiksen, J. L., Heinzlef, O., Karageorgiou, K. E., Lander Delgado, R. H., Landtblom, A.-M., Macías Islas, M. A., Tubridy, N., & Gilgun-Sherki, Y. (2015, jan.). Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial. Journal of Neurology https://doi.org/10.1007/s00415-014-7565-7

Ziemssen, T, Bajenaru, OA, Carrá, A, de Klippel, N, Correia de Sá, J, Edland, A, Frederiksen, JL, Heinzlef, O, Karageorgiou, KE, Lander Delgado, RH, Landtblom, A-M, Macías Islas, MA, Tubridy, N & Gilgun-Sherki, Y 2015, Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.. https://doi.org/10.1007/s00415-014-7565-7

@misc{d1cb8b8449ad451b8d277553e7d57790,

title = "Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial",

author = "Tjalf Ziemssen and Bajenaru, {Ovidiu A} and Adriana Carr{\'a} and {de Klippel}, Nina and {Correia de S{\'a}}, Jo{\~a}o and Astrid Edland and Frederiksen, {Jette L} and Olivier Heinzlef and Karageorgiou, {Klimentini E} and {Lander Delgado}, {Rafael H} and Anne-Marie Landtblom and {Mac{\'i}as Islas}, {Miguel A} and Niall Tubridy and Yossi Gilgun-Sherki",

year = "2015",

month = jan,

doi = "10.1007/s00415-014-7565-7",

language = "English",

volume = "262",

series = "Journal of Neurology",

publisher = "Dr. Dietrich/Steinkopff Verlag",

type = "Other",

}

TY - GEN

T1 - Erratum to

T2 - A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

AU - Ziemssen, Tjalf

AU - Bajenaru, Ovidiu A

AU - Carrá, Adriana

AU - de Klippel, Nina

AU - Correia de Sá, João

AU - Edland, Astrid

AU - Frederiksen, Jette L

AU - Heinzlef, Olivier

AU - Karageorgiou, Klimentini E

AU - Lander Delgado, Rafael H

AU - Landtblom, Anne-Marie

AU - Macías Islas, Miguel A

AU - Tubridy, Niall

AU - Gilgun-Sherki, Yossi

PY - 2015/1

Y1 - 2015/1

U2 - 10.1007/s00415-014-7565-7

DO - 10.1007/s00415-014-7565-7

M3 - Other contribution

C2 - 25417969

VL - 262

T3 - Journal of Neurology

ER -